Additionally, FXR activation enhances insulin sensitivity through various mechanisms [258], such as reducing hepatic steatosis [259], enhancing lipid metabolism [248,260], and exerting anti-inflammatory effects [261]. This evidence concerns the gene NR1H4 and Hepatic steatosis.